Cargando…
Influence of temperature management at 33 °C versus normothermia on survival in patients with vasopressor support after out-of-hospital cardiac arrest: a post hoc analysis of the TTM-2 trial
BACKGROUND: Targeted temperature management at 33 °C (TTM33) has been employed in effort to mitigate brain injury in unconscious survivors of out-of-hospital cardiac arrest (OHCA). Current guidelines recommend prevention of fever, not excluding TTM33. The main objective of this study was to investig...
Autores principales: | Düring, Joachim, Annborn, Martin, Cariou, Alain, Chew, Michelle S., Dankiewicz, Josef, Friberg, Hans, Haenggi, Matthias, Haxhija, Zana, Jakobsen, Janus C., Langeland, Halvor, Taccone, Fabio Silvio, Thomas, Matthew, Ullén, Susann, Wise, Matt P., Nielsen, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339193/ https://www.ncbi.nlm.nih.gov/pubmed/35909163 http://dx.doi.org/10.1186/s13054-022-04107-9 |
Ejemplares similares
-
Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial
por: Robba, Chiara, et al.
Publicado: (2022) -
Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial
por: Düring, Joachim, et al.
Publicado: (2020) -
Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial
por: Robba, Chiara, et al.
Publicado: (2022) -
Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan
por: Jakobsen, Janus Christian, et al.
Publicado: (2020) -
Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators
por: Moseby-Knappe, Marion, et al.
Publicado: (2022)